151 related articles for article (PubMed ID: 32193201)
1. Incidence of type 2 diabetes in familial combined hyperlipidemia.
Brouwers MCGJ; de Graaf J; Simons N; Meex S; Ten Doeschate S; van Heertum S; Heidemann B; Luijten J; de Boer D; Schaper N; Stehouwer CDA; van Greevenbroek MMJ
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32193201
[TBL] [Abstract][Full Text] [Related]
2. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids.
Brouwers MC; Bilderbeek-Beckers MA; Georgieva AM; van der Kallen CJ; van Greevenbroek MM; de Bruin TW
Clin Sci (Lond); 2007 Jan; 112(2):123-30. PubMed ID: 16958621
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up study.
Luijten J; van Greevenbroek MMJ; Schaper NC; Meex SJR; van der Steen C; Meijer LJ; de Boer D; de Graaf J; Stehouwer CDA; Brouwers MCGJ
Atherosclerosis; 2019 Jan; 280():1-6. PubMed ID: 30448567
[TBL] [Abstract][Full Text] [Related]
4. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass.
Keulen ET; Voors-Pette C; de Bruin TW
Am J Hypertens; 2001 Apr; 14(4 Pt 1):357-63. PubMed ID: 11336182
[TBL] [Abstract][Full Text] [Related]
5. Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia.
Brouwers MC; van der Kallen CJ; Schaper NC; van Greevenbroek MM; Stehouwer CD
Neth J Med; 2010 Apr; 68(4):163-7. PubMed ID: 20421657
[TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
[TBL] [Abstract][Full Text] [Related]
7. Abdominal obesity and expression of familial combined hyperlipidemia.
van der Kallen CJ; Voors-Pette C; de Bruin TW
Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
[TBL] [Abstract][Full Text] [Related]
8. Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.
Brouwers MC; Govers-Riemslag J; Schalkwijk CG; van Greevenbroek MM; van der Kallen CJ; Bekers O; van Dieijen-Visser MP; Ten Oever J; Bilderbeek-Beckers MA; de Bruin TW; Ten Cate H; Stehouwer CD
Thromb Res; 2008; 122(4):466-72. PubMed ID: 18262228
[TBL] [Abstract][Full Text] [Related]
9. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study.
Olubamwo OO; Virtanen JK; Pihlajamaki J; Tuomainen TP
BMJ Open; 2019 Jul; 9(7):e026949. PubMed ID: 31278098
[TBL] [Abstract][Full Text] [Related]
10. Increased arterial stiffness in familial combined hyperlipidemia.
Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
[TBL] [Abstract][Full Text] [Related]
11. FABP4 plasma levels are increased in familial combined hyperlipidemia.
Cabré A; Lázaro I; Cofán M; Jarauta E; Plana N; Garcia-Otín AL; Ascaso JF; Ferré R; Civeira F; Ros E; Masana L
J Lipid Res; 2010 May; 51(5):1173-8. PubMed ID: 20388924
[TBL] [Abstract][Full Text] [Related]
12. Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E; Farahani N; Mardani R; Taheri F; Taghizadeh H; Gheibihayat SM
Biochem Genet; 2022 Apr; 60(2):453-481. PubMed ID: 34478023
[TBL] [Abstract][Full Text] [Related]
13. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.
Pihlajamäki J; Rissanen J; Heikkinen S; Karjalainen L; Laakso M
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1039-44. PubMed ID: 9194752
[TBL] [Abstract][Full Text] [Related]
14. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia.
Brouwers MC; Cantor RM; Kono N; Yoon JL; van der Kallen CJ; Bilderbeek-Beckers MA; van Greevenbroek MM; Lusis AJ; de Bruin TW
J Lipid Res; 2006 Dec; 47(12):2799-807. PubMed ID: 16971732
[TBL] [Abstract][Full Text] [Related]
15. Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids.
van den Berg EH; Flores-Guerrero JL; Gruppen EG; de Borst MH; Wolak-Dinsmore J; Connelly MA; Bakker SJL; Dullaart RPF
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917546
[TBL] [Abstract][Full Text] [Related]
16. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
Franch-Nadal J; Caballeria L; Mata-Cases M; Mauricio D; Giraldez-García C; Mancera J; Goday A; Mundet-Tudurí X; Regidor E;
PLoS One; 2018; 13(6):e0198327. PubMed ID: 29856820
[TBL] [Abstract][Full Text] [Related]
17. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.
van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW
Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806
[TBL] [Abstract][Full Text] [Related]
18. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood.
Shamir R; Tershakovec AM; Gallagher PR; Liacouras CA; Hayman LL; Cortner JA
Atherosclerosis; 1996 Mar; 121(1):85-91. PubMed ID: 8678927
[TBL] [Abstract][Full Text] [Related]
19. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
[TBL] [Abstract][Full Text] [Related]
20. Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?
Karjalainen L; Pihlajamäki J; Karhapää P; Laakso M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1548-53. PubMed ID: 9763525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
